Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Filed Nov 4, 2016 · 10-Q · 35 days after period end · 0001144204-16-131724
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Net Income | -$2.10M | $28.50M | -$1.57M | -$744.65K |
| EPS Diluted | -$0.29 | $4.23 | -$0.09 | -$0.76 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 4, 2016 · 35 d after period end
